Antares Therapeutics
Latest round
- Series A
Last raised
- May 2025
Total raised
- $30M
Investors
- 10
About Antares Therapeutics
Antares Therapeutics, Inc.Antares Therapeutics, Inc. specializes in creating targeted therapies for challenging medical conditions, primarily in oncology. The company was founded to advance the treatment of serious illnesses through cutting-edge scientific research. It is headquartered in Boston, US. The CEO is Adam Friedman, who has a background in founding similar biotech ventures.AntaresRX specializes in the development of precision medicines aimed at transforming patient care, particularly in oncology. The company's core offerings include next-generation small molecule therapeutics targeting previously undruggable proteins, specifically transcription factors and mutant EGFR inhibitors for non-small cell lung cancer. These therapies address significant unmet medical needs by leveraging advanced technologies in medicinal chemistry, target biology, and predictive sciences.AntaresRX generates revenue through collaborations and partnerships with pharmaceutical companies, which fund the development and commercialization of its therapeutic products. This includes joint development agreements and licensing deals, with the company receiving upfront payments, milestone payments based on developmental success, and royalties on future sales. The company aims to introduce new therapeutics in its pipeline while targeting expansion into additional markets in North America and Europe.
Who invested in Antares Therapeutics
10 investors across 1 round
See all investors in Antares Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 1, 2025
Amount
$30M
Investors
Questions about Antares Therapeutics
Who invested in Antares Therapeutics?
Antares Therapeutics has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antares Therapeutics raised?
Antares Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Antares Therapeutics last raise money?
Antares Therapeutics's most recent round on record is a Series A, in May 2025.
What does Antares Therapeutics do?
Antares Therapeutics is a biotechnology company.
Where is Antares Therapeutics headquartered?
Antares Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Antares Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Antares Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Antares Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.